Definition: POCT refers to the analysis of biological specimens outside of the central laboratory. Common alternative terms include:
Near patient testing
Bedside testing
Ancillary testing
Extra-laboratory testing
Decentralized testing
Quick Turnaround Time:
Timely results facilitate quicker clinical decisions and interventions.
Reduces hospital stay as waiting time for lab results is minimized.
Accelerates patient transfer to appropriate wards.
Optimized Drug Treatment:
More precise drug usage tailored to patient needs.
Less reliance on blood products (e.g., Rotem).
Resource Efficiency:
Potential reductions in laboratory staffing and equipment usage, although this may vary.
Enables care of elderly/frail patients in community settings, allowing treatment in the comfort of their homes.
Delays in the Pathway:
Flow: Sample booking → Analysis → Result release.
Can include delays from sample transport or staff availability, affecting patient care.
Cost:
Devices can be expensive (e.g., D-dimer testing costs around £20 per test for POCT vs. less than £5 in a lab due to bulk operations).
Quality of Results:
Results may be less reliable from clinical staff compared to trained laboratory technicians.
Needs stringent risk assessments due to varied experience levels among POCT operators.
Training and Certification:
Challenges in training due to large operator numbers compared to lab staff (3000 operators vs. <10 lab staff).
Business Case Development: Budget must sustain the lifecycle of the device (minimum contract values: £10,000).
Device Verification: Team includes various specialists (scientists, admin, IT) for thorough oversight.
Training: Required for all healthcare staff interacting with POCT.
Daily Maintenance: Vital for the operational integrity of devices.
POCT Committee: Develops and oversees guidelines aligned with organizational policies.
Testing Environment:
Should be designated 'clean' areas with easy access to handwashing facilities and IT equipment.
Requirements for dedicated rooms include proper electrical supply, safe storage, and access controls.
Evaluate processes, reagents, and chemicals based on COSHH guidelines.
Mistakes during sampling or data entry can lead to wrong patient results.
Quality control measures (IQC/EQA) are essential to prevent systematic errors in testing.
Types of Technologies:
Benchtop Analyzers: Smaller versions of laboratory systems.
Handheld Devices: Portable and easier to access at bedside.
Testing Methods:
Lateral Flow Tests: Basic qualitative tests requiring confirmatory testing (e.g., for drugs or pregnancy).
Reflection Photometry: Measures substance concentration.
Electrochemical Glucose Meters: Provide rapid and sensitive measurement results.
Spectrophotometry and Potentiometry: Used in blood gas analysis to determine various biochemical parameters.
Levy Jennings Plot: Utilized for assessing variability and accuracy in test results.
Continuous monitoring ensures reliability in patient testing over time.
Pregnancy Testing:
hCG testing can provide qualitative assessments to confirm or rule out pregnancy, but additional quantitative measures are needed to understand pregnancy status (e.g., ectopic or miscarriage).
Blood Gas Analysis:
Essential for maintaining acid-base homeostasis and understanding patient health.
Measurement of parameters like pH, pCO2, and electrolytes are critical for accurate patient assessment.
POCT is rapidly evolving, providing significant benefits in patient care through timely and decentralized testing, albeit with challenges in implementation and operational costs.
Ensuring quality and safety through training and thorough operational policies remains paramount to patient outcomes and effective healthcare delivery.